Annual operating revenue of Jiangsu Hengrui Pharmaceuticals 2022, by product category
In 2022, the Chinese pharmaceutical giant Jiangsu Hengrui Pharmaceuticals generated more than 11 billion yuan of income from anticancer drugs. The company is a market leader in oncology medications in China and was among the